INVESTORS & MEDIA
Event
American Society of Retina Specialists Annual Meeting: 2-year (96 week) data from Phase 2/3 PHOTON (DME) study
Jul 292023 Jul 29, 2023
These slides contain the 2-year (96 weeks) results from the Phase 2/3 PHOTON study of aflibercept 8 mg for DME. The presentation was given by Diana V. Do, MD at the American Society of Retina Specialists Annual Meeting on July 29, 2023.